Not the best day for the prosecution in the Barry Bonds case

20 Comments

It was a short day for the Bonds trial — they must all want to get home in time to watch the Giants-Dodgers — and they are now wrapped up for the week.  A bad morning for the prosecution, though, as Bonds’ former orthopedic surgeon, Arthur Ting, totally killed one of the prosecution’s key witnesses, Steve Hoskins.

Hoskins testified last week that he had discussed his concerns about Bonds’ steroids use with Ting many times. In fact, Hoskins said more than 50 times during his testimony. And when he did, Bonds’ lawyer asked him “are you sure about that?” I questioned that at the time, but we now know why he said it:  today Ting said that he and Hoskins only had one cursory exchange ever about steroids. And that it wasn’t even about Bonds. It was just a request for generic steroids information.

That testimony kills Hoskins’ credibility, it seems to me. Seems to be the case for the prosecutors too, who admitted that Hoskins had been “impeached heavily” by Ting’s testimony. And it seemed that way to the judge too, as she later grilled the prosecutors about whether they knew of these inconsistencies outside of the presence of the jury. Between an angry judge and the fact that Hoskins is the guy who has had the most to say about Bonds’ steroids use, this is a big problem for the prosecution.

Also helpful for Bonds was Ting’s testimony that all of Bonds’ alleged steroids symptoms — described by Kimberly Bell — could have been caused by corticosteroids that Ting prescribed for Bonds following surgery he had in 1999, undercutting the notion that such symptoms had to have been called by anabolic steroids supplied by BALCO and Greg Anderson.

After Ting came Kathy Hoskins, Bonds’ former personal shopper and sister of Steve Hoskins. She was far better for the prosecution, testifying that she actually saw Greg Anderson inject Barry Bonds with something on one occasion.  This could, if it holds up, be enough for a conviction on one count inasmuch as Bonds testified that Anderson never injected him with anything and was charged with lying about it. It does not seem, however, that she knew what the substance was, though she did say that Bonds referred to it as something that was “undetectable” and that he took it before road trips. Still, it is likely not enough to get him on the “did you take steroids” counts by itself.

After Hoskins came anti-doping expert Don Catlin, who testified about how his organization figured out what “the clear” was, testifying about how difficult it was to detect. Seems to me that the more they play up the high-tech nature of the substance the less likely it is that a dumb baseball player would be able to understand it, but really, it doesn’t seem to do a ton for either the defense or the prosecution.

All in all a fairly big day: two of the most significant witnesses against Bonds — Kimberly Bell and Steve Hoskins — were harmed. However, Bonds may have been sunk on the count regarding taking injections.  I think the defense will take that trade.

Brewers to give Mike Moustakas a look at second base

Thearon W. Henderson/Getty Images
8 Comments

The Brewers reportedly signed third baseman Mike Moustakas to a one-year, $10 million contract on Sunday. While the deal is not yet official, MLB.com’s Adam McCalvy reports that the Brewers plan to give Moustakas a look at second base during spring training. If all goes well, he will be the primary second baseman and Travis Shaw will stay at third base.

The initial thought was that Moustakas would simply take over at third base for the more versatile Shaw. Moustakas has spent 8,035 of his career defensive innings at third base, 35 innings at first base, and none at second. In fact, he has never played second base as a pro player. Shaw, meanwhile, has spent 268 of his 4,073 1/3 defensive innings in the majors at second base and played there as recently as October.

This is certainly an interesting wrinkle to signing Moustakas, who is a decent third baseman. He was victimized by another slow free agent market, not signing until March last year on a $6.5 million deal with a $15 million mutual option for this season. That option was declined, obviously, and he ended up signing for $5 million cheaper here in February as the Brewers waited him out. Notably, Moustakas did not have qualifying offer compensation attached to him this time around.

Last season, between the Royals and Brewers, the 30-year-old Moustakas hit .251/.315/.459 with 28 home runs and 95 RBI in 635 plate appearances.